Eli Lilly's tirzepatide set the bar for weight loss. In a study leading to Zepbound's approval, patients given the highest ...

A key study used in securing FDA approval for Wegovy as a lifetime medication for weight loss was based on patients using the ...

Novo Nordisk braced for a congressional inquiry into the high prices of weight loss and diabetes drugs, particularly Ozempic, ...

The CEO of Novo Nordisk is set to appear before a Senate panel today to be grilled on the high cost of Ozempic and Wegovy, ...

A Copeland, fornecedora global de soluções climáticas sustentáveis e líder nos setores de HVAC, refrigeração e compressão industrial, anunciou que Jagadish Keswani ingressará na Copeland como ...

This summary covers various health news briefs including AstraZeneca's breast cancer drug trial results, a bird flu case in ...

It plans to use the fresh proceeds to expand in the US and other markets, improve its GenAI foundation models, and fund ...

In a high-profile showdown Tuesday with Sen. Bernie Sanders’ Senate health committee, Novo Nordisk CEO Lars Fruergaard ...

New public and private entrants are emerging to challenge the leading positions of Novo Nordisk NVO and Eli Lilly LLY in a ...

Good evening! The last full-size Kmart store in the United States is closing. On a brighter note, the Philadelphia Phillies ...

The CEO of Novo Nordisk will testify in the Senate HELP Committee tomorrow about the cost of popular diabetes and weight loss ...

What the results might mean for the future of other developers in the cannabinoid receptor 1 (CB1) weight-loss arena came into question after Novo Nordisk A/S unveiled phase IIa findings with ...